Antibody Detection & Identification Review

Slides:



Advertisements
Similar presentations
Practical Blood Bank Lab Adsorption.
Advertisements

THE DIRECT ANTIGLOBULIN TEST (DAT) and Elution/Eluate Testing
Dr. Mohammed H Saiemaldahr BLOOD BANK MED TECH
Antibody Identification
“It’s Just a Panel … It’s not Rocket Science”
Investigative Techniques in Blood Banking
Case Study: Weird Wonderful Walter
COMPATIBILITY TESTING
CLS 3311 Advanced Clinical Immunohematology
BASIC ANTIBODY IDENTIFICATION
Antibody Identification
September 2007 Dr Debra Lane
When can you use an antibody to find another antibody?
Hemolytic Disease of the Newborn Case #3
Practical Blood Bank Antibody Screening Lab 6.
Identifying Antibodies
ANTIGLOBULIN TEST and ANTIBODY DETECTION
Antiglobulin Test (Coomb’s Test)
Major Blood Groups ABO.
Interesting Case Studies from The Mayo Clinic Reference Laboratory Georgette Benidt, MT(ASCP)
Antibody Identification
2 pt 3 pt 4 pt 5pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2pt 3 pt 4pt 5 pt 1pt 2pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4pt 5 pt 1pt DEFINITIONS NAME THAT ANTIGEN DISEASE.
2 pt 3 pt 4 pt 5pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2pt 3 pt 4pt 5 pt 1pt 2pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4pt 5 pt 1pt REACTIVITY NAME THAT ANTIBODY COLDSGENETICS.
Detecting Antibodies The Antibody Screen CLS 422
Drmsaiem. OTHER BLOOD GROUPS DR MOHAMMED H SAIEM ALDAHR Faculty of Applied Medical Sciences MED TECH DEP. 3 RD YEAR MT.
Unit 8 Pretransfusion Testing Part 3
Antibody Detection Mohammed Jaber.
Detection and Identification of alloantibodies to Red Cell Antigens
Case Study #1 Marilyn Telen, MD Duke University.
Unit 9 Other Blood Group Systems Part 2
ABO/D Blood Groups Understanding Critical For Safe Transfusions.
The Antiglobulin Test Nada Mohamed Ahmed , MD, MT (ASCP)i.
Antibody Screening / Detection & Antibody Identification
Immunologic Methods Part One Antigen-Antibody Reactions CLS 420 Clinical Immunology & Molecular Diagnostics.
Antibody Screening and Identification
Alloantibodies causing Hemolytic Disease of the Newborn and Fetus. Nancy Benitez, BS, MHS (ASCP)SBB CM Reference Laboratory Director June 6, 2013.
INCOMPLETE CROSSMATCH
The need is constant. The gratification is instant. Give blood. TM Transfusion Medicine Case Studies Patient GJ March 2010 John N. McLennan, MT(ASCP) Midwest.
Compatibility Testing (cross matching)
Unit 8 Pretransfusion Testing Part 2
Welcome Back to Immunohematology Other Antigen Systems Part II – Kell, Duffy, Kidd, MNSs.
Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results.
Serological Cases: What keeps us up at Night Stephanie Goe, MT (AAB-P) June 6, 2013.
When can you use an antibody to find another antibody?
Antiglobulin Test.
An unpleasant visitor? The challenge of having a red cell antibody visit the lab Dr. Aseem Kumar Tiwari 1 1.
Pretranfusion Compatibility Testing Mr. Mohammed A. Jaber.
Identification of antibody mixes that give a complete covering of diagnostic panels reactions. Identification of weak, only partially reacting antibodies.
Practical Blood Bank Lab 4 Weak D testing (Du).
Compatibility Testing practical NO 4 Dr: Dalia Kamal Eldien.
Serological Testing In Blood Transfusion Services
Nada Mohamed Ahmed , MSc, MT (ASCP)i
Terry Kotrla, MS, MT(ASCP)BB Unit 8 Pretransfusion Testing Part 1.
Other Blood Group Systems
lecture 10 blood bank Compatibility Testing
Compatibility Testing  Compatibility testing is performed to determine if a particular unit of blood can be transfused safely into a certain patient.
Part III. Essentials of Pretransfusion Testing.
Practical Blood Bank Lab 3 Rh Grouping.
Welcome Back to Immunohematology Other Antigen Systems Part III – Lewis, P, Lutheran, Xg, I.
Reagents and Methods for Testing in the Blood Bank
Cross-matching as part of Pre transfusion compatibility
Compatibility Testing
Pretranfusion Compatibility Testing Mr. Mohammed A. Jaber.
Coombs test practical(3)
Detection and Identification of alloantibodies to Red Cell Antigens
Mayhem – Get More Information
Practical Blood Bank Lab 4 Weak D testing (Du).
Adsorption Mr. Mohammed A. jaber.
Use of select cells in Immunohematology
Practical Blood Bank Lab 4 Weak D testing (Du).
Presentation transcript:

Antibody Detection & Identification Review CLS 423 Clinical Immunohematology Advanced Antibody Identification Module

Objectives After viewing this presentation, the student will be able to: Apply appropriate exclusion/inclusion techniques to antibody identification Select cells to be tested in order to complete an antibody identification Prove within 95% confidence that the antibody identification is correct Select appropriate positive and negative controls for antigen typing

Antibody Screen Results Vial D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S Lua Xga Pt AHG I + 3+ II III Assume that testing was performed using the tube technique with LISS enhancement. Immediate spin (IS) and 37oC phases showed no reactivity with all 3 screen cells. Coombs Control Cells (CC) added to tubes II and III after the AHG phase were 2+ positive.

How would you interpret the results of the antibody screen? Positive Negative Unable to interpret (Click on one of the buttons to register your choice)

How would you interpret the results of the antibody screen? CORRECT! Click here to continue Positive Negative Unable to interpret

How would you interpret the results of the antibody screen? Incorrect. The antibody screen in this case is positive. (3+ reaction with screen cell I) Positive Negative Unable to interpret

What is the next appropriate step? Antigen type patient’s red blood cells Perform a panel using patient’s plasma or serum Repeat the screen using prewarmed patient’s serum and screen cells No additional testing is necessary (Click on one of the buttons above to register your choice)

No additional testing is necessary Sorry…there is more work to be done to resolve this case. Click here to review the other options

Antigen Type Patient’s RBCs This step is premature. The antibodies should be identified first. Which action would you like to take? Perform a panel Repeat the screen using prewarmed technique No additional testing is necessary (Click on one of the buttons above to register your choice)

Prewarm Technique This action is not appropriate in this case. There is no evidence of interference from a cold antibody. Which action would you like to take? Antigen type patient’s red blood cells Perform a panel No additional testing is necessary

Perform a Panel This would be the most useful step to take next in resolving this case.

Initial Panel Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells

“THE RULES” Exclude using only cells that failed to react with the serum (negative) Exclude an antibody when the cell has homozygous antigen expression Exceptions: K, Kpa, Jsa, and Lua can be ruled out when they are present on a cell with heterozygous or homozygous expression If anti-D is in the plasma, then C and E can be excluded using a cell with heterozygous expression If anti-D is not in the plasma, C and E must be ruled out using a cell with homozygous antigen expression

Find a cell with … Homozygous expression of E 3 Cell # D C c E e Cw K Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells Homozygous expression of E 3

Find a cell with … Heterozygous expression of M 2, 4, 5, 6, 9 Cell # D Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells Heterozygous expression of M 2, 4, 5, 6, 9

Homozygous vs. Heterozygous Homozygous – only one allele of the pair is present on the cell C + c - Heterozygous – both alleles of the pair are present on the cell C+ c+

Initial Panel Results Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells Take a moment to determine what antibodies can be excluded based on the results of the initial panel.

Initial Panel Results Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells

Initial Panel Results What antibodies are you unable to exclude? C, E, Cw, K, Kpa, Jsa, Fyb, Jka, N, S, & Lua Does any single antibody explain all of the positive results? NO What is the significance of the auto control result? No autoantibodies are present

Can any additional antibodies be excluded based on the antibody screen results? Vial D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S Lua Xga Pt AHG I + 3+ II III If so, what are they? E, Fyb, & N

C, Cw, K, Kpa, Jsa, Jka, S, & Lua have not been excluded What is the next appropriate step to take in order to complete the antibody identification? Antigen type the patient’s red blood cells Fill the rule of 3 & 3 to provide 95% confidence in the antibody identification Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel Treat panel cells with enzymes and repeat testing

Antigen type the patient’s RBCs Antigen typing for this many antigens will be more time consuming than other steps that could be taken. Antigen typing for this many antigens is generally not cost effective. Anti-sera for typing some of these antigens (Cw, Kpa, Jsa, & Lua) may not be readily available What step would you like to take instead? Fill the rule of 3 & 3 to provide 95% confidence in the antibody identification Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel Treat panel cells with enzymes and repeat testing

Fill the rule of 3 & 3 There are too many antibodies that have not been excluded to begin examining the probability that these reactions are caused by antibodies and not just by random chance. What step would you like to take instead? Antigen type the patient’s red blood cells Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel Treat panel cells with enzymes and repeat testing

Enzyme Panel C, Cw, K, Kpa, Jsa, Jka, S, & Lua have not been excluded C, Cw, and Jka show stronger antigen expression when cells are treated with enzymes S is destroyed by enzymes K, Kpa, Jsa, and Lua are unaffected by routine enzymes May not provide adequate separation of antibodies in this case There is a better choice for this case What step would you like to take instead? Antigen type the patient’s red blood cells Fill the rule of 3 & 3 to provide 95% confidence in the antibody identification Test selected cells to eliminate or confirm the presence of the antibodies that were not excluded from the initial panel

Selected Cells This would be a useful step to take at this point C, Cw, K, Kpa, Jsa, Jka, S, & Lua have not been excluded All but Lua are clinically significant Cw, Kpa, Jsa & Lua are low prevalence antigens. It may be difficult to find cells that are antigen positive to use for exclusion

Selected Cells Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 2 3 4 5 6 7 8 9 10 11 Pt Cells These cells are available for use in a selected cell panel. Take a moment to decide which cells you would like to test.

The yellow highlighted cells would make a good selected cell panel for this case Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 2 2+ 3 4 3+ 5 6 7 8 9 10 11 Pt Cells Other cells on this panel could be run, but would have more overlap in antigens. Additional cells may need to be tested as a result.

Selected Cell Panel Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 2 2+ 3 4 3+ 5 6 7 8 9 10 11 Pt Cells

Selected Cell Results What antibodies are present in this specimen? Anti-K and anti- Jka Are there clinically significant antibodies that still cannot be excluded? Anti- Jsa Anti-Lua is not excluded, but is generally considered insignificant

What to do when an antibody cannot be excluded? Type the patient for the antigen. If the patient is antigen positive, he should not be able to make the antibody. If the antibody is to a low prevalence antigen (like the anti-Jsa in this case), it may not be possible to exclude it with the available reagents. In most cases, a compatible antiglobulin crossmatch is considered “proof” that a unit of red blood cells would be safe to transfuse the patient (“crossmatch compatible” blood vs. antigen negative blood) If the unit was positive for the low prevalence antigen, and the patient had the antibody, the crossmatch should be incompatible. It may be necessary to send the specimen to a reference laboratory to prove or exclude an antibody to a low prevalence antigen.

List the phenotypes of cells that need to be tested in order to prove this ID with 95% confidence? 3 cells that are K+ Jka – that react + 3 cells that are K- Jka + that react + 3 cells that are K- Jka – that react – Has this been filled with the cells that have already been tested? NO What cells still need to be tested? Need one more cell that is K+ Jka – that reacts +

What additional step should be taken to confirm this ID? Absorb out the anti-Jka using a Jka + K- cell to “unmask” the anti-K Antigen type the patient’s red blood cells Fill the rule of 3 & 3 Perform a DAT using the patient’s red blood cells (Click on one of the buttons above to register your choice)

Absorption Not necessary at this point, since the selected cell panel has already demonstrated these 2 specificities What other action would you take? Antigen type the patient’s red blood cells Fill the rule of 3 & 3 Perform a DAT using the patient’s red blood cells (Click on one of the buttons above to register your choice)

Rule of 3 & 3 This is the 95% confidence rule. If there is a cell available, one more cell that is K+ Jka – should be tested to fill this rule. We would expect this cell to react +. What other step should be performed? Absorb out the anti-Jka using a Jka + K- cell to “unmask” the anti-K Antigen type the patient’s red blood cells Perform a DAT using the patient’s red blood cells

Perform DAT Not necessary in this case. Auto control would have been positive if the patient had a positive DAT. What other action would you take? Absorb out the anti-Jka using a Jka + K- cell to “unmask” the anti-K Antigen type the patient’s red blood cells Fill the rule of 3 & 3

Antigen Typing What would be the expected results of antigen typing? K… Neg Jka …

Using this panel, select positive and negative controls for K antigen typing Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells

K Controls Positive Control Negative Control Cell 2 or 7 Any of the remaining cells

Using this panel, select positive and negative controls for Jka antigen typing Cell # D C c E e Cw K k Kpa Jsa Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga AHG CC 1 + 3+ 2 2+ 3 4 5 6 7 8 9 10 11 Pt Cells

Jka Controls Positive Negative Cell 3, 6, 7, or 11 Must be heterozygous in order to detect the weakest amount of antigen present Negative Cell 2, 4, 5, or 10

How would you prepare packed RBC units for this patient? Antigen type units for K & Jka Perform an antiglobulin crossmatch

# units ordered /(freq. Jka - x freq. K-) If the physician ordered 6 units of packed RBCs for this patient, how many units would need to be antigen typed in order to find compatible units? 6/(.33 x .91) = 19.98 # units ordered /(freq. Jka - x freq. K-) Type 20 units to find 6 antigen negative units

The End Please complete the 8 Antibody Identification – Advanced Methods case studies and the assigned TracQ cases.